just saw Harvard Bioscience doing a reverse split on their stock - 1-for-10 consolidation hitting March 16th. shares tanked 12% overnight right after the announcement, dropped from $0.55 to $0.47. so basically every 10 shares become 1, cutting the outstanding count from 44.7M down to 4.47M. timing is interesting because they're reporting Q4 results the day before the split takes effect. stock's been beaten down pretty hard this past year, bouncing between $0.28 and $0.95. reverse splits usually mean the company's trying to get the share price up, but market didn't like it at all. they're also adjusting all the options and warrants proportionally. not sure if this is a sign of trouble or just a technical move, but the nordics-style consolidation play doesn't seem to be resonating with investors right now. anyone holding this or watching it?